Top Markets
#1 ADO Protocol ADO Protocol +329.21%
#2 GoPlus Security GoPlus Security +55.29%
#3 Starpower Starpower +48.47%
#4 The Black Bull The Black Bull +35.43%
#5 Nockchain Nockchain +33.90%
#6 Verus Coin Verus Coin +33.62%
#7 Tutorial Tutorial +33.25%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.73%
#9 GAIB AID GAIB AID +24.67%
#10 Chainflip Chainflip +24.30%
Coin of the day
ADO Protocol ADO Protocol
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
NuCana plc NuCana plc

NuCana plc

NCNA
Xếp hạng trong cổ phiếu #32773
NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering... NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platform. Among its key drug candidates, Acelarin is progressing through multiple clinical evaluations: a Phase I study for advanced solid tumors, Phase Ib trials for both recurrent ovarian cancer and biliary tract cancer, a Phase II trial targeting platinum-resistant ovarian cancer, and a pivotal Phase III trial for pancreatic cancer. NuCana is also developing NUC-3373, a ProTide derivative of 5-fluorouracil’s active anti-cancer metabolite. This compound is currently in a Phase I study for advanced solid tumors and a Phase Ib/2 trial for advanced colorectal cancer. Additionally, NUC-7738, a nucleoside analog, is undergoing Phase 1/2 clinical assessment for both advanced solid and hematological malignancies. To support its ProTide technology development, the company maintains research, collaboration, and licensing agreements with Cardiff University and University College Cardiff Consultants Ltd., covering the design, synthesis, characterization, and assessment of these compounds. Further collaborative and licensing arrangements are in place with Cardiff ProTides Ltd. Established in 1997, the company operated as NuCana BioMed Limited before rebranding to NuCana plc in August 2017. Its corporate headquarters are located in Edinburgh, United Kingdom.
Giá cổ phiếu
$1.51
Vốn hóa thị trường
$9.14M
Thay đổi (1 ngày)
-5.35%
Thay đổi (1 năm)
-59.65%
Quốc gia
GB
Giao dịch NuCana plc (NCNA)

Danh mục

Healthcare
Lịch sử chia tách cổ phiếu của NuCana plc (NCNA)
Cổ phiếu NuCana plc (mã: NCNA) đã trải qua tổng cộng 0 lần chia tách.
Lần chia tách gần nhất diễn ra vào ngày Aug 17, 2026.
Một cổ phiếu NCNA mua trước ngày Aug 17, 2026 hiện tương đương với 0 cổ phiếu NCNA.
Danh sách chia tách cổ phiếu
Năm Chia tách Tỷ lệ Tỷ lệ cộng dồn
Không đủ dữ liệu cho ngày được cung cấp.
Chia tách cổ phiếu của các công ty tương tự hoặc đối thủ
Công ty Số lần chia tách cổ phiếu Tỷ lệ cộng dồn Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE